Combined systemic and topical treatment of disordered tissues
AssigneeQuadex Pharmaceuticals, LLC
InventorB. RON JOHNSON
Life of this patent
Estimating the term…
Loading patent…
AssigneeQuadex Pharmaceuticals, LLC
InventorB. RON JOHNSON
Estimating the term…
Kits and methods for treating disordered tissue caused by a virus in a mammal involve co-administration of a systemic anti-virus drug and topically administering an anti-infective composition. The systemic anti-virus drug is internally administered and disrupts or inhibits virus replication systemically within the mammal. Examples include nucleoside analogues, nucleoside analogue precursors, and nucleotide analogues. The topically administered anti-infective composition includes at least one anti-infective agent, such as an organohalide (e.g., benzalkonium chloride), and is formulated to penetrate below the disordered tissue surface and allow the anti-infective agent to kill viruses at the disordered tissue site. The anti-infective composition reduces the time and/or number of dosages required for the systemic anti-virus drug to treat the disordered tissue in the absence of topically administering the anti-infective composition. It also reduces or eliminates incidences of post-treatment neuralgia.
A method of treating disordered tissue caused by a virus in a mammal, comprising:
A method of treating disordered tissue caused by a virus in a mammal, comprising:
A kit for use in treating disordered tissue caused by a virus in a mammal, comprising:
Dependencies are inferred from the claim text.